Yu-Jin Kwon1,2, Suk-Yong Jang3, Eun-Cheol Park3, A-Ra Cho1, Jae-Yong Shim1, John A Linton1,4. 1. Department of Family Medicine, Yonsei University College of Medicine, Seoul, Korea. 2. Department of Medicine, Graduate School, Yonsei University, Seoul, Republic of Korea. 3. Department of Preventive Medicine and Institute of Health Services Research, Yonsei University College of Medicine, Seoul, Korea. 4. International Health Care Center, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Abstract
STUDY OBJECTIVES: Sarcopenia, or loss of muscle mass, occurs with aging and results in frailty, disability, cardiovascular disease, and insulin resistance. Recently, researchers have asserted that sarcopenia is not an inevitable process, but is a modifiable condition. Adequate sleep duration is also important to maintain good physical and mental health. Therefore, the aim of our study was to examine the association between sleep duration and sarcopenia in Korean adults. METHODS: Data from 16,148 participants (7,158 men and 8,990 women) were analyzed from the 2008-2011 Korean National Health and Nutrition Examination Survey (KNHANES). We defined sarcopenia as one standard deviation below the sex-specific means of the appendicular skeletal muscle/height-squared values of a young reference group. Participants were categorized into 5 groups according to sleep duration. The odds ratios (OR) and 95% confidence intervals (95% CI) for sarcopenia according to sleep duration were calculated using multiple logistic regression analysis. RESULTS: The prevalence of sarcopenia was 14.3% in the total population (males 18.7%, females 9.7%). Compared to the 7 hours of sleep group, the OR (95% CI) for sarcopenia of the long sleep duration group (9 hours or more) was 1.589 (1.100-2.295) after controlling for confounding factors. From the results of subgroup analysis, high-risk groups for sarcopenia are as follows: 40-64 years old (OR = 1.868), normal body mass index (OR = 1.516), smoking (OR = 2.219), no regular exercise (OR = 1.506) in long sleepers. CONCLUSIONS: Long sleep duration (9 hours or longer) is independently associated with sarcopenia in Korean adults.
STUDY OBJECTIVES:Sarcopenia, or loss of muscle mass, occurs with aging and results in frailty, disability, cardiovascular disease, and insulin resistance. Recently, researchers have asserted that sarcopenia is not an inevitable process, but is a modifiable condition. Adequate sleep duration is also important to maintain good physical and mental health. Therefore, the aim of our study was to examine the association between sleep duration and sarcopenia in Korean adults. METHODS: Data from 16,148 participants (7,158 men and 8,990 women) were analyzed from the 2008-2011 Korean National Health and Nutrition Examination Survey (KNHANES). We defined sarcopenia as one standard deviation below the sex-specific means of the appendicular skeletal muscle/height-squared values of a young reference group. Participants were categorized into 5 groups according to sleep duration. The odds ratios (OR) and 95% confidence intervals (95% CI) for sarcopenia according to sleep duration were calculated using multiple logistic regression analysis. RESULTS: The prevalence of sarcopenia was 14.3% in the total population (males 18.7%, females 9.7%). Compared to the 7 hours of sleep group, the OR (95% CI) for sarcopenia of the long sleep duration group (9 hours or more) was 1.589 (1.100-2.295) after controlling for confounding factors. From the results of subgroup analysis, high-risk groups for sarcopenia are as follows: 40-64 years old (OR = 1.868), normal body mass index (OR = 1.516), smoking (OR = 2.219), no regular exercise (OR = 1.506) in long sleepers. CONCLUSIONS: Long sleep duration (9 hours or longer) is independently associated with sarcopenia in Korean adults.
Authors: Najib T Ayas; David P White; JoAnn E Manson; Meir J Stampfer; Frank E Speizer; Atul Malhotra; Frank B Hu Journal: Arch Intern Med Date: 2003-01-27
Authors: Antonia K Coppin; Luigi Ferrucci; Fulvio Lauretani; Caroline Phillips; Miran Chang; Stefania Bandinelli; Jack M Guralnik Journal: J Gerontol A Biol Sci Med Sci Date: 2006-01 Impact factor: 6.053
Authors: Edith M C Lau; Henry S H Lynn; Jean W Woo; Timothy C Y Kwok; L Joseph Melton Journal: J Gerontol A Biol Sci Med Sci Date: 2005-02 Impact factor: 6.053
Authors: Edward M Castillo; Deborah Goodman-Gruen; Donna Kritz-Silverstein; Deborah J Morton; Deborah L Wingard; Elizabeth Barrett-Connor Journal: Am J Prev Med Date: 2003-10 Impact factor: 5.043
Authors: Blake B Rasmussen; Satoshi Fujita; Robert R Wolfe; Bettina Mittendorfer; Mona Roy; Vincent L Rowe; Elena Volpi Journal: FASEB J Date: 2006-02-07 Impact factor: 5.191
Authors: Xiao Tan; Olga E Titova; Eva Lindberg; Sölve Elmståhl; Lars Lind; Helgi B Schiöth; Christian Benedict Journal: J Clin Sleep Med Date: 2019-03-15 Impact factor: 4.062
Authors: Jacobo Á Rubio-Arias; Raquel Rodríguez-Fernández; Luis Andreu; Luis M Martínez-Aranda; Alejandro Martínez-Rodriguez; Domingo J Ramos-Campo Journal: J Clin Med Date: 2019-12-06 Impact factor: 4.241